Overall, we identified that p53R175H mutation in LC contributes to aggressiveness of the tumor through ST6GalNAc‐I/MUC5AC pathway (Fig. 7). This evidence concerns the gene ST6GALNAC1 and laryngotracheoesophageal cleft.